These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1116 related items for PubMed ID: 23038639

  • 41. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
    Ravindranath N, Wion D, Brachet P, Djakiew D.
    J Androl; 2001; 22(3):432-43. PubMed ID: 11330643
    [Abstract] [Full Text] [Related]

  • 42. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
    White JD, Hewett PW, Kosuge D, McCulloch T, Enholm BC, Carmichael J, Murray JC.
    Cancer Res; 2002 Mar 15; 62(6):1669-75. PubMed ID: 11912138
    [Abstract] [Full Text] [Related]

  • 43. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
    Issa A, Le TX, Shoushtari AN, Shields JD, Swartz MA.
    Cancer Res; 2009 Jan 01; 69(1):349-57. PubMed ID: 19118020
    [Abstract] [Full Text] [Related]

  • 44. Vascular endothelial growth factor-D: signaling mechanisms, biology, and clinical relevance.
    Achen MG, Stacker SA.
    Growth Factors; 2012 Oct 01; 30(5):283-96. PubMed ID: 22817635
    [Abstract] [Full Text] [Related]

  • 45. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.
    Anticancer Res; 2002 Oct 01; 22(6C):3977-84. PubMed ID: 12553021
    [Abstract] [Full Text] [Related]

  • 46. VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels.
    Secker GA, Harvey NL.
    Dev Dyn; 2015 Mar 01; 244(3):323-31. PubMed ID: 25399804
    [Abstract] [Full Text] [Related]

  • 47. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M, Kitadai Y, Tanaka M, Kuwai T, Tanaka S, Oue N, Yasui W, Chayama K.
    Clin Cancer Res; 2008 Nov 15; 14(22):7205-14. PubMed ID: 19010837
    [Abstract] [Full Text] [Related]

  • 48. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
    Huang JH, Li Y, Liu L, Yang HC, Hai J, Tang LL, Hu TH.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb 15; 31(1):36-9, 51. PubMed ID: 16562672
    [Abstract] [Full Text] [Related]

  • 49. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H, Shijubo N, Yamada G, Ichimiya S, Abe S, Satoh M, Sato N.
    Cancer; 2005 Oct 15; 104(8):1668-77. PubMed ID: 16116610
    [Abstract] [Full Text] [Related]

  • 50. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.
    Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, Pytowski B, Skobe M.
    Cancer Res; 2006 Mar 01; 66(5):2650-7. PubMed ID: 16510584
    [Abstract] [Full Text] [Related]

  • 51. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO.
    Cancer Res; 2005 Nov 01; 65(21):9789-98. PubMed ID: 16267000
    [Abstract] [Full Text] [Related]

  • 52. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis.
    Tsurusaki T, Kanda S, Sakai H, Kanetake H, Saito Y, Alitalo K, Koji T.
    Br J Cancer; 1999 Apr 01; 80(1-2):309-13. PubMed ID: 10390013
    [Abstract] [Full Text] [Related]

  • 53. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
    Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C, Horsfall DJ, Tilley WD.
    Cancer Res; 2002 Feb 01; 62(3):854-9. PubMed ID: 11830543
    [Abstract] [Full Text] [Related]

  • 54. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
    Jüttner S, Wissmann C, Jöns T, Vieth M, Hertel J, Gretschel S, Schlag PM, Kemmner W, Höcker M.
    J Clin Oncol; 2006 Jan 10; 24(2):228-40. PubMed ID: 16344322
    [Abstract] [Full Text] [Related]

  • 55. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B, Flister MJ, Bagaitkar J, Volk L, Bivens CM, Pickett B, Castro-Rivera E, Brekken RA, Gerard RD, Ran S.
    Int J Cancer; 2007 Nov 15; 121(10):2181-91. PubMed ID: 17597103
    [Abstract] [Full Text] [Related]

  • 56. Interaction of tumor cells and lymphatic vessels in cancer progression.
    Alitalo A, Detmar M.
    Oncogene; 2012 Oct 18; 31(42):4499-508. PubMed ID: 22179834
    [Abstract] [Full Text] [Related]

  • 57. Immunohistochemical localization of vascular endothelial growth factor receptors-1, -2 and -3 in human spinal cord: altered expression in amyotrophic lateral sclerosis.
    Spliet WG, Aronica E, Ramkema M, Witmer AN, Schlingemann RO, de Jong JM, Troost D.
    Neuropathol Appl Neurobiol; 2004 Aug 18; 30(4):351-9. PubMed ID: 15305980
    [Abstract] [Full Text] [Related]

  • 58. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
    Tokuyama W, Mikami T, Masuzawa M, Okayasu I.
    Hum Pathol; 2010 Mar 18; 41(3):407-14. PubMed ID: 19913279
    [Abstract] [Full Text] [Related]

  • 59. Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
    Maekawa S, Iwasaki A, Shirakusa T, Enatsu S, Kawakami T, Kuroki M, Kuroki M.
    Anticancer Res; 2007 Mar 18; 27(6A):3735-41. PubMed ID: 17970036
    [Abstract] [Full Text] [Related]

  • 60. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma.
    Tanigaki Y, Nagashima Y, Kitamura Y, Matsuda H, Mikami Y, Tsukuda M.
    Int J Mol Med; 2004 Sep 18; 14(3):389-95. PubMed ID: 15289890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.